Sublocade provides continuous buprenorphine release for a month by which mechanism?

Sublocade provides continuous buprenorphine release for a month by which mechanism?

• A. Immediate-release
• B. Delayed-release only
• C. Continuous release over a month
• D. No release

Answer: (C)

The idea being tested is how long-acting injectable medications deliver drug. Sublocade is an extended‑release buprenorphine given as a monthly subcutaneous injection. After administration, it forms a subcutaneous depot and buprenorphine is released continuously over about a month, keeping steady therapeutic drug levels and supporting ongoing treatment. This is why the best choice is continuous release over a month. It’s not immediate-release, which would push most of the drug out quickly and require frequent dosing; it’s not a delayed-release with a gap before release, since release starts promptly and continues; and it’s not no release, since the drug is indeed released over the month.

The idea being tested is how long-acting injectable medications deliver drug. Sublocade is an extended‑release buprenorphine given as a monthly subcutaneous injection. After administration, it forms a subcutaneous depot and buprenorphine is released continuously over about a month, keeping steady therapeutic drug levels and supporting ongoing treatment. This is why the best choice is continuous release over a month. It’s not immediate-release, which would push most of the drug out quickly and require frequent dosing; it’s not a delayed-release with a gap before release, since release starts promptly and continues; and it’s not no release, since the drug is indeed released over the month.